Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

  • There is currently no data for BMK

PCA Dealing

29 Nov 2021 14:38

RNS Number : 9228T
Benchmark Holdings PLC
29 November 2021
 

29 November 2021

BENCHMARK HOLDINGS PLC (THE "COMPANY")

The Company has been informed that Ferd AS ("Ferd"), who is associated with Kristian Eikre, subscribed for 12,267,227 ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 62 pence per share in the placing announced by the Company on 29 November 2021.

Following this transaction, Ferd has a total beneficial interest in the Company of 185 374 388 Ordinary Shares, representing approximately 26.3 per cent. of the Company's issued share capital.

The Notification of Dealing Form below is made in accordance with the Market Abuse Regulation (EU) no. 596/2014 (as amended) as it forms part of the domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 (as amended).

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Ferd AS

2

Reason for the notification

a)

Position/status

Person closely associated

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Benchmark Holdings plc

b)

LEI

2138001UQHM4VZGXUJ19

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares in Benchmark Holdings plc

 

 

GB00BGHPT808

b)

Nature of the transaction

Share acquisition

c)

Price(s) and volume(s)

Price(s)

Volume(s)

62

pence

12,267,227

d)

Aggregated information

- Aggregated volume

- Price

Aggregate Price

Aggregate Volume

Aggregate Total

62

pence

12,267,227

ÂŁ7,605,680.74

e)

Date of the transaction

29 November 2021

f)

Place of the transaction

Outside a trading venue

 

For further information from Benchmark Holdings plc, please contact:

Benchmark Holdings plc

Tel: 020 3696 0630

Trond Williksen, CEO

 

Septima Maguire, CFO

 

Ivonne Cantu, Investor Relations

 

 

Numis Securities Ltd (NOMAD)

Tel: 020 7260 1000

James Black, Freddie Barnfield, Duncan Monteith

 

 

 

MHP Communications

Tel: 020 3128 8990 / 8742

Katie Hunt, Reg Hoare, Alistair de Kare-Silver, Charlie Protheroe

benchmark@mhpc.com

IMPORTANT NOTICES

This Announcement has been prepared by, and is the sole responsibility of, the Directors of Benchmark Holdings plc.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEALFNADSFFFA
Date   Source Headline
17th Jan 20234:35 pmRNSPrice Monitoring Extension
11th Jan 20238:00 amRNSPosting of Notice of AGM
30th Dec 20227:00 amRNSTotal Voting Rights
16th Dec 20229:58 amRNSHolding(s) in Company
15th Dec 20227:00 amRNSFirst Day of Trading on Euronext Growth Oslo
14th Dec 20229:15 amRNSCompletion of private placement & retail offering
13th Dec 20224:30 pmRNSSufficient number of shares in VPS
6th Dec 20226:21 pmRNSSuccessful private placement and retail offering
6th Dec 20227:00 amRNSLast day of bookbuilding and application period
1st Dec 20223:36 pmRNSPublication of Annual Report and Notice of AGM
1st Dec 202210:58 amRNSStatus of bookbuilding
1st Dec 20227:00 amRNSProspectus & Commencement of Bookbuilding Period
30th Nov 202210:00 amRNSTotal Voting Rights
30th Nov 20227:01 amRNSPrivate Placing & Retail Offering
30th Nov 20227:00 amRNSQ4 Results
30th Nov 20227:00 amRNSFull Year Results
25th Nov 20227:00 amRNSNotice of Results
14th Nov 20224:40 pmRNSSecond Price Monitoring Extn
14th Nov 20224:35 pmRNSPrice Monitoring Extension
14th Nov 20224:35 pmRNSChange of Registered Office
31st Oct 20227:00 amRNSTotal Voting Rights
24th Oct 20227:00 amRNSTrading Update
19th Oct 20227:00 amRNSHolding(s) in Company
12th Oct 20224:41 pmRNSSecond Price Monitoring Extn
12th Oct 20224:35 pmRNSPrice Monitoring Extension
5th Oct 20224:35 pmRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSTotal Voting Rights
21st Sep 20227:00 amRNSBlock listing Six Monthly Return
20th Sep 20227:00 amRNSBenchmark hosts Capital Markets Day today
16th Sep 20227:00 amRNSRefinances the Company's existing debt
15th Sep 20224:35 pmRNSPrice Monitoring Extension
6th Sep 20227:00 amRNSFixed Income Investor Meetings
31st Aug 20227:00 amRNSTotal Voting Rights
25th Aug 20227:00 amRNSQ3 Results
1st Aug 20227:00 amRNSNotice of Q3 Results
29th Jul 20227:00 amRNSTotal Voting Rights
14th Jul 20227:00 amRNSNotice of Capital Markets Day and Site Visit
1st Jul 202212:08 pmRNSHolding(s) in Company
30th Jun 20227:00 amRNSTotal Voting Rights
16th Jun 20224:41 pmRNSSecond Price Monitoring Extn
16th Jun 20224:36 pmRNSPrice Monitoring Extension
1st Jun 20227:00 amRNSConversion of loan into green loan
31st May 20227:00 amRNSTotal Voting Rights
23rd May 20225:15 pmRNSDirector Dealings
20th May 20221:05 pmRNSDirector Dealings
18th May 20227:00 amRNSSecond Quarter and Interim results
3rd May 20227:00 amRNSMarket Authorisation Update
29th Apr 20222:29 pmRNSTotal Voting Rights
28th Apr 20227:00 amRNSNotice of Q2 and Interim Results
21st Apr 20223:17 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.